Aniort, Julien http://orcid.org/0000-0001-9541-1264
Piraud, Aurélien
Adda, Mireille
Perreira, Bruno
Bouiller, Marc
Fourcade, Jacques
Guerraoui, Abdallah
Kalbacher, Emilie
Krumel, Thierry
Moragues, Hélène Leray
Thibaudin, Damien
Vela, Carlos Gustavo
Vernin, Guillaume
Weclawiak, Hugo
Bernard, Lise
Heng, Anne Elisabeth
Souweine, Bertrand
Funding for this research was provided by:
French Ministry of Health (Protocole Hospitalier de Recherche Clinique PHRC national 2015)
Article History
Received: 22 October 2018
Accepted: 15 April 2019
First Online: 30 April 2019
Ethics approval and consent to participate
: The protocol, the information and consent forms, and the investigator’s brochure on Ethenox have received authorization from the “cpp-sudest6” (AU 1269) ethics committee and the Agence National de Sécurité du Médicament et des produits de santé (ANSM) (2016-A00180-51). The investigator explain the study to the patient and give him/her the information form. The patients willing to participate in the study sign a written consent form.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.